Impact of prior HAART use on clinical outcomes in a large Kenyan HIV treatment program.

Publication Type:

Journal Article


Current HIV research, Volume 7, Issue 4, p.441-6 (2009)


2009, Adult, Africa, Anti-HIV Agents, Antiretroviral Therapy, Highly Active, Body Weight, CD4 Lymphocyte Count, Center-Authored Paper, Female, HIV Infections, Humans, KENYA, Longitudinal Studies, Male, Middle Aged, Public Health Sciences Division, Treatment Outcome


HIV treatment programs in Africa typically approach all enrolling patients uniformly. Growing numbers of patients are antiretroviral experienced. Defining patients on the basis of antiretroviral experience may inform enrollment practices, particularly if medical outcomes differ.